- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 311/29 - Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
Patent holdings for IPC class C07C 311/29
Total number of patents in this class: 316
10-year publication summary
|
22
|
27
|
16
|
16
|
20
|
12
|
17
|
15
|
13
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ardelyx, Inc. | 115 |
7 |
| Novartis AG | 10744 |
6 |
| F. Hoffmann-La Roche AG | 7947 |
6 |
| The Regents of the University of Michigan | 4711 |
6 |
| Baylor College of Medicine | 950 |
6 |
| China Pharmaceutical University | 301 |
6 |
| Icahn School of Medicine at Mount Sinai | 951 |
6 |
| Tvardi Therapeutics, Inc. | 32 |
6 |
| Peloton Therapeutics, Inc. | 37 |
5 |
| University of Tsukuba | 616 |
5 |
| Boehringer Ingelheim International GmbH | 4642 |
4 |
| Canopy Growth Corporation | 220 |
4 |
| Eastern Michigan University | 31 |
4 |
| Merck Canada Inc. | 87 |
4 |
| The University of Melbourne | 537 |
4 |
| Mangosuthu University of Technology | 4 |
4 |
| Orsobio, Inc. | 13 |
4 |
| Glaxo Group Limited | 4063 |
3 |
| The Regents of the University of California | 19961 |
3 |
| Merck Patent GmbH | 5815 |
3 |
| Other owners | 220 |